|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.920
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.907
|
Human Zebrafish |
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.807
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.773
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.750
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.726
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.693
|
|
|
|
regulation of serine type endopeptidase activity
|
GO:1900003 |
2 |
0.651
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.613
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.612
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.560
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.553
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.552
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.547
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.514
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.514
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.501
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.497
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.416
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.383
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.367
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.364
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.363
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.328
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.312
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.311
|
|
|
|
medium chain fatty acid metabolic process
|
GO:0051791 |
1 |
0.305
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.302
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.295
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.289
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.283
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.277
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.274
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.258
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.253
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.251
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.251
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.245
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.224
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.222
|
Human |
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.219
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.214
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.211
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.206
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.202
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.199
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.198
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.192
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.188
|
Human |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.183
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.179
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.177
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.172
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.171
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.170
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.164
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.163
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.162
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.159
|
Human |
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.159
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.158
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.158
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.157
|
Human |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.157
|
|
|
|
protein n linked glycosylation
|
GO:0006487 |
12 |
0.155
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.155
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.149
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.146
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.145
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.141
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.141
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.135
|
Human |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.129
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.127
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.126
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.126
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.126
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.120
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.119
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.111
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.110
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.109
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.109
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.109
|
Human |
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.106
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.105
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.102
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.100
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.100
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.097
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.096
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.095
|
Human |
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.095
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.093
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.091
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.091
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.090
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.089
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.088
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.088
|
Human |
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.088
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.086
|
|
|
|
secondary metabolite catabolic process
|
GO:0090487 |
1 |
0.085
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.083
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.082
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.081
|
|
|
|
toxin catabolic process
|
GO:0009407 |
1 |
0.077
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.077
|
Human |
|
|
humoral immune response
|
GO:0006959 |
57 |
0.077
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.077
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.077
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.076
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.075
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.075
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.075
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.075
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.074
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.074
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.074
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.074
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.073
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.073
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.071
|
|
|
|
aspartate family amino acid metabolic process
|
GO:0009066 |
10 |
0.071
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.070
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.070
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.069
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.069
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.069
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.068
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.068
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.066
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.066
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.066
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.065
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.065
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.063
|
Human |
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.063
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.062
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.062
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.059
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.058
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.057
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.057
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.056
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.056
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.055
|
Human |
|
|
protein processing
|
GO:0016485 |
163 |
0.055
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.054
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.054
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.053
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.053
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.052
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.052
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.051
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.051
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.051
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.050
|
Human |
|
|
glycosylation
|
GO:0070085 |
62 |
0.050
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.049
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.049
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.048
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.048
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.048
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.048
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.047
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.047
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.046
|
|
|
|
opsonization
|
GO:0008228 |
3 |
0.045
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.045
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.045
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.045
|
Human |
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.044
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.044
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.042
|
Human |
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.042
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.041
|
Human |
|
|
circulatory system process
|
GO:0003013 |
197 |
0.041
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.041
|
Human |
|
|
organ regeneration
|
GO:0031100 |
2 |
0.041
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.041
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.041
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.041
|
Human |
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.040
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.040
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.040
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.040
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.039
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.039
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.039
|
Human |
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.039
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.039
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.039
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.039
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.039
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.038
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.038
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
|
|
|
anion homeostasis
|
GO:0055081 |
16 |
0.038
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.037
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.037
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.036
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.035
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.035
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.035
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.034
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.034
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.034
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.034
|
Human |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.033
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.033
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.033
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.033
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.032
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.032
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.032
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.032
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.031
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.031
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.031
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.030
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
Human |
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.029
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.029
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.029
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.028
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.028
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.028
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
Human |
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.028
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.028
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.027
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.027
|
|
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.027
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.026
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.026
|
Human |
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.026
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.026
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.026
|
Human |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.026
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.025
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.025
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.025
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.025
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.025
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.025
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.024
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.024
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.024
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.023
|
Human |
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.023
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.023
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.023
|
Human |
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.023
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.023
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.023
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.022
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.022
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.022
|
|
|
|
nadh metabolic process
|
GO:0006734 |
1 |
0.022
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.022
|
Human |
|
|
cofactor transport
|
GO:0051181 |
4 |
0.022
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.022
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.022
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.022
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.022
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.022
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.021
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.021
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.021
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.021
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.021
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.021
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.020
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.020
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.020
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.020
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.020
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.020
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.020
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.020
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.020
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.020
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.019
|
|
|
|
heme transport
|
GO:0015886 |
2 |
0.019
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.019
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.019
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.019
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.019
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.019
|
|
|
|
ovulation from ovarian follicle
|
GO:0001542 |
9 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.019
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.018
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.018
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.018
|
Human |
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.018
|
Human |
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.018
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.017
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.017
|
Human |
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.017
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.017
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.017
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.016
|
Human |
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.016
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.016
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.016
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.016
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.016
|
Human |
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.016
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.016
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.016
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.016
|
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.016
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.015
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.015
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.015
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.015
|
|
|
|
regulation of blood volume by renin angiotensin
|
GO:0002016 |
7 |
0.015
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.015
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.015
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.015
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.015
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.015
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.015
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.015
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.015
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.015
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.014
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.014
|
Human |
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.014
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
|
regulation of tyrosine phosphorylation of stat1 protein
|
GO:0042510 |
2 |
0.014
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.014
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.014
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.014
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.014
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.014
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.014
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.014
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.014
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.014
|
|
|
|
regulation of phospholipase activity
|
GO:0010517 |
9 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.013
|
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.013
|
Human |
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.013
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.013
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.013
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.013
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.013
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.013
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.013
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.013
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.013
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.013
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.013
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.013
|
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.013
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.013
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.013
|
|
|
|
positive regulation of protein maturation
|
GO:1903319 |
7 |
0.013
|
|
|
|
regulation of cholesterol biosynthetic process
|
GO:0045540 |
8 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.012
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.012
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.012
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.012
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.012
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.012
|
|
|
|
aspartate family amino acid biosynthetic process
|
GO:0009067 |
5 |
0.012
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.012
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.012
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.012
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.012
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.012
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.012
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.012
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.012
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.012
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.012
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.012
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.012
|
Human |
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.012
|
|